Quick Answer
Onconetix, Inc. reported Total Revenue of $815.4 thousand for fiscal year 2025.
Onconetix, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $815.4K | -67.7% |
| 2024 | $2.52M | +4217.3% |
| 2023 | $58.5K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $303.7K | -25.4% | +185.1% |
| June 30, 2025 | $106.5K | -84.9% | +4.8% |
| March 31, 2025 | $101.6K | -85.5% | -75.0% |
| September 30, 2024 | $406.9K | — | -42.3% |
| June 30, 2024 | $704.8K | — | +0.6% |
| March 31, 2024 | $700.4K | — | — |
- Onconetix, Inc. showed a decrease of -67.7% in Total Revenue compared to the prior fiscal year.
- Over the 2023–2025 period, Onconetix, Inc.’s total revenue has grown by 1294.6% (from $58.5 thousand to $815.4 thousand).
- The most recent figure is from Onconetix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: